Table 2 - Randomized trials comparing proton pump inhibitors and H2-receptor antagonists in the management of peptic esophageal strictures
From the following article
Reflux esophagitis and peptic strictures
Lars Lundell
GI Motility online (2006)
doi:10.1038/gimo43
| Authors | No. of patients | Therapy (mg) | F/U (mo) | % needing repeat dilation | % free of dysphagia |
|---|---|---|---|---|---|
LAN, lanzoprazole; OME, omerprazole; RA, ranitidine | |||||
| Smith et al., 1994 | 180 | OME 20 | 12 | 30% | 76% |
| 185 | RAN 300 | 46% | 64% | ||
| Swarbrick et al., 1996 | 70 | LAN 30 | 12 | 36% | – |
| 71 | RAN 300 | 51% | – | ||
| Marks et al., 1994 | 18 | OME 20 | 6 | 41% | – |
| 16 | RAN 300 | 73% | – | ||
| Allakhverdyan et al., 2003 | 15 | OME 20 | 10 | 33% | 80% |
| 17 | RAN 300 | 53% | 70% | ||
© 2019 Nature is part of Springer Nature. All Rights Reserved.
